Cardio Diagnostics Holdings Inc. (CDIO)

From the record

Cardio Diagnostics Holdings Inc.'s filings since 2021 show 7 warning events of 2 kinds: a notice about its exchange listing (8-K item 3.01, 5 times, the latest 2024-12-04); an auditor change (8-K item 4.01, 2 times, the latest 2022-11-10) (its current reports).

From the record

Cardio Diagnostics Holdings Inc.'s 5 filed years say what it did: revenue went from $1 thousand in fiscal 2021 to $15 thousand in fiscal 2025, up 101.4% a year; it rose in 3 of 4 years; the deepest fall was 58% from fiscal 2024 to fiscal 2025; net income was positive in 0 of 5 of those years (its annual reports).

From the record

Return on equity: in the fiscal year ended 2025-12-31, Cardio Diagnostics Holdings Inc. lost about 93 cents for every dollar of shareholders' money. Leverage: it owed about 10 cents per dollar of assets, and net share issuance: its share count grew 95.4% over the year (the filed statements).

From the record

Cardio Diagnostics Holdings Inc.'s standing among 17 graded names in its industry family: revenue of $15 thousand in fiscal 2025 ranks in the bottom 9% by size; a net margin of -43832.5% ranks in the bottom 9%; revenue growth of 149.8% a year over the last 3 filed years ranks in the top 3% (its annual reports).

From the record

Cardio Diagnostics Holdings Inc.'s leadership, from its insiders' filings and its current reports: no one files under a chief executive's title, so that part is not read; the 4 officers and directors filing in the last fifteen months have been on the record a median of 2.3 years (bottom 11%); no officer or director change was reported on Form 8-K since 2023-11-13, against the 4 people in charge now (top 3%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

Cardio Diagnostics Holdings Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $5 million against no long-term debt tagged leaves 65.8% of its assets as net cash, top 3% of its family; cash from operations less capital spending is -39893.1% of revenue (bottom 9%); research spending of 4325.2% of revenue (top 16%) (its annual report).

From the record

Cardio Diagnostics Holdings Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew 149.8% a year over the last three filed years against 101.4% over all 5, speeding up (top 3% of its family); the newest year grew -57.5% (bottom 15%); research spending grew 151.2% a year (top 3%); capital spending grew -42.9% a year (bottom 23%) (its annual reports). Cardio Diagnostics Holdings Inc. tags no split of its revenue by line in the annual report on file, so growth by line cannot be read here; research and capital spending are on the trend.

From the record

Cardio Diagnostics Holdings Inc.'s newest year against its own record: revenue of $15 thousand in fiscal 2025 came in 93% below the $211 thousand its prior three years' pace pointed to (bottom 3% of its family); net income of $6 million against a prior three-year average of $7 million (bottom 47%); a net margin of a loss larger than its revenue against losses larger than its revenue before (top 3%) (its annual reports).